Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 85 (5), 339-343

Familial Hypercholesterolemia: Cascade Screening in Children and Relatives of the Affected

Affiliations

Familial Hypercholesterolemia: Cascade Screening in Children and Relatives of the Affected

Nitika Setia et al. Indian J Pediatr.

Abstract

Objective: Familial Hypercholesterolemia (FH) is an inherited disorder of lipid metabolism characterized by very high low density lipoprotein (LDL) cholesterol since birth, resulting in premature atherosclerosis and coronary artery disease (CAD). Cascade screening of children and family members of proven FH individuals can identify more subjects who have high LDL cholesterol or the family mutation and appropriate intervention can reduce their risk of atherosclerosis and prevent its complications.

Methods: Cascade screening by molecular testing, was carried out in 133 family members, comprising 24 children, of 31 probands with FH having a pathogenic mutation in LDLR/ApoB gene. Lipid profiles were obtained in 44 family members including 11 children.

Results: Of 133 family members tested, 88 (66.1%) were identified to carry the family mutation. Twelve of these were children below 18 y of age and 76 were adults. CAD was present in 15 (11.2%) family members and 63(47.4%) family members, including nine children, were already on Lipid Lowering Therapy.

Conclusions: Cascade screening led to identification of 88 new cases, with a pathogenic mutation, who were at a very high risk of developing premature CAD. The authors identified 12 children with family specific mutation, out of which 9 were initiated on low dose statin therapy. Four homozygous children were treated with high dose statins because of substantially increased risk of CAD. Cascade screening, therefore, proved to be a successful initiative towards primary prevention of CAD in India.

Keywords: Cascade screening; Children; Familial hypercholesterolemia; Genetic testing.

Comment in

Similar articles

  • Familial Hypercholesterolemia.
    Youngblom E, Pariani M, Knowles JW. Youngblom E, et al. 2014 Jan 2 [updated 2016 Dec 8]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020. GeneReviews®. 1993–2020. PMID: 24404629 Free Books & Documents. Review.
  • Lipid phenotype and heritage pattern in families with genetic hypercholesterolemia not related to LDLR, APOB, PCSK9, or APOE.
    Jarauta E, Pérez-Ruiz MR, Pérez-Calahorra S, Mateo-Gallego R, Cenarro A, Cofán M, Ros E, Civeira F, Tejedor MT. Jarauta E, et al. J Clin Lipidol. 2016 Nov-Dec;10(6):1397-1405.e2. doi: 10.1016/j.jacl.2016.09.011. Epub 2016 Sep 22. J Clin Lipidol. 2016. PMID: 27919357
  • Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia.
    Khera AV, Won HH, Peloso GM, Lawson KS, Bartz TM, Deng X, van Leeuwen EM, Natarajan P, Emdin CA, Bick AG, Morrison AC, Brody JA, Gupta N, Nomura A, Kessler T, Duga S, Bis JC, van Duijn CM, Cupples LA, Psaty B, Rader DJ, Danesh J, Schunkert H, McPherson R, Farrall M, Watkins H, Lander E, Wilson JG, Correa A, Boerwinkle E, Merlini PA, Ardissino D, Saleheen D, Gabriel S, Kathiresan S. Khera AV, et al. J Am Coll Cardiol. 2016 Jun 7;67(22):2578-89. doi: 10.1016/j.jacc.2016.03.520. Epub 2016 Apr 3. J Am Coll Cardiol. 2016. PMID: 27050191 Free PMC article.
  • Genetic testing of familial hypercholesterolemia in a real clinical setting.
    Vohnout B, Gabcova D, Huckova M, Klimes I, Gasperikova D, Raslova K. Vohnout B, et al. Wien Klin Wochenschr. 2016 Dec;128(23-24):916-921. doi: 10.1007/s00508-016-1053-2. Epub 2016 Aug 19. Wien Klin Wochenschr. 2016. PMID: 27542166
  • Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel.
    Sturm AC, Knowles JW, Gidding SS, Ahmad ZS, Ahmed CD, Ballantyne CM, Baum SJ, Bourbon M, Carrié A, Cuchel M, de Ferranti SD, Defesche JC, Freiberger T, Hershberger RE, Hovingh GK, Karayan L, Kastelein JJP, Kindt I, Lane SR, Leigh SE, Linton MF, Mata P, Neal WA, Nordestgaard BG, Santos RD, Harada-Shiba M, Sijbrands EJ, Stitziel NO, Yamashita S, Wilemon KA, Ledbetter DH, Rader DJ; Convened by the Familial Hypercholesterolemia Foundation. Sturm AC, et al. J Am Coll Cardiol. 2018 Aug 7;72(6):662-680. doi: 10.1016/j.jacc.2018.05.044. J Am Coll Cardiol. 2018. PMID: 30071997 Review.
See all similar articles

Cited by 3 articles

References

    1. JAMA. 2017 Jul 25;318(4):381-382 - PubMed
    1. Pediatrics. 2008 Jul;122(1):198-208 - PubMed
    1. Eur Heart J. 2015 Sep 21;36(36):2425-37 - PubMed
    1. J Pediatr Pharmacol Ther. 2010 Jul;15(3):160-72 - PubMed
    1. Atheroscler Suppl. 2017 Nov;30:77-85 - PubMed

LinkOut - more resources

Feedback